NOTVInotiv, Inc.
0.3076USD+9.04%Mkt Cap: 10.76M USDP/E: Last update: 2026-06-01

Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. The company operate…

Indicators:|

Key Statistics

Company
Market Cap10.76M USD
Enterprise Value482.56M USD
Revenue (TTM)507.36M USD
Gross Profit120.98M USD
Net Income (TTM)-68.63M USD
Revenue/Share14.73 USD
Last Price0.3076 USD
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees1.9K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISINUS45783Q1004
Valuation
P/E (Trailing)
P/E (Forward)-5.72
PEG
EV/EBITDA56.38
EV/Revenue0.95
P/S0.02
P/B0.13
EPS (TTM)-2.48
EPS (Forward)-0.05
52W Range
0.22003% of range3.320
52W High3.320 USD
52W Low0.2200 USD
Profitability
Gross Margin23.58%
Oper. Margin-16.03%
EBITDA Margin1.69%
Profit Margin-13.38%
ROE-50.45%
ROA-8.90%
Growth
Revenue Growth-5.40%
Earnings Growth
Cash Flow & Leverage
Operating CF-10.46M USD
CapEx (TTM)16.61M USD
FCF Margin4.66%
FCF Yield219.60%
Net Debt472.59M USD
Net Debt/EBITDA55.22
Balance Sheet
Debt/Equity3.38
Current Ratio0.27
Quick Ratio0.15
Book Value/Sh2.210 USD
Cash/Share0.4350 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating
Target (Mean)3.250 USD
Target Range1.500 USD5.000 USD
# Analysts2
Ownership
Shares Out.34.89M
Float32.32M
Insiders9.02%
Institutions14.00%
Short Interest
Short Ratio2.5d
Short % Float9.47%
Short % Out.8.72%
Shares Short3.04M
Short (prev mo.)2.72M
Technical
SMA 500.2874 (+7.0%)
SMA 2000.7955 (-61.3%)
Beta3.83
S&P 52W Chg27.94%
Avg Vol (30d)711.67K
Avg Vol (10d)806.98K
Technical Indicators
RSI (14)49.3
MACD-0.0055
MACD Signal-0.0060
MACD Hist.+0.0005
BB Upper0.3253 USD
BB Middle0.2854 USD
BB Lower0.2456 USD
BB Width27.93%
ATR (14)0.0304 USD
Vol Ratio (20d)0.41x